Over 30 years of drug and device development experience.  Most recently served as the Chief Growth Officer at WCG Clinical, responsible for the company’s enterprise growth and commercialization strategy.  Prior to WCG, was Elligo Health Research’s COO where she furthered company’s growth, efficiency and mission of optimizing the intersection of healthcare and research.  Dawn was also the Chief Development Officer at Clinipace (now Caidya) where she developed the strategy and grew the organization to be a trusted partner for sponsors.  Prior roles included President, Development Innovations at Sarah Cannon and SVP and General Manager Hematology/Oncology at inVentiv Health (now Syneos).

Back to Advisory Committee